ALK-Abelló A/S (LON:0OIR)
London flag London · Delayed Price · Currency is GBP · Price in DKK
205.64
+3.19 (1.58%)
At close: Sep 10, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Sublingual Immunotherapy-Tablets
2.85B
Log In
Log In
Log In
Log In
Upgrade
Sublingual Immunotherapy-Tablets Growth
24.17%
Log In
Log In
Log In
Log In
Upgrade
Subcutaneous Immunotherapy/Sublingual Immunotherapy-Drops
2.05B
Log In
Log In
Log In
Log In
Upgrade
Subcutaneous Immunotherapy/Sublingual Immunotherapy-Drops Growth
5.83%
Log In
Log In
Log In
Log In
Upgrade
Other Products and Services
634.00M
Log In
Log In
Log In
Log In
Upgrade
Other Products and Services Growth
7.64%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Europe
2.13B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
14.61%
Log In
Log In
Log In
Log In
Upgrade
Germany
978.50M
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
38.30%
Log In
Log In
Log In
Log In
Upgrade
North America
779.16M
Log In
Log In
Log In
Log In
Upgrade
North America Growth
2.16%
Log In
Log In
Log In
Log In
Upgrade
International
717.00M
Log In
Log In
Log In
Log In
Upgrade
International Growth
13.81%
Log In
Log In
Log In
Log In
Upgrade
France
665.38M
Log In
Log In
Log In
Log In
Upgrade
France Growth
21.70%
Log In
Log In
Log In
Log In
Upgrade
Denmark
141.00M
Log In
Log In
Log In
Log In
Upgrade
Denmark Growth
35.58%
Log In
Log In
Log In
Log In
Upgrade
United States
126.84M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-12.69%
Log In
Log In
Log In
Log In
Upgrade
Japan
-
Log In
Log In
Log In
Log In
Upgrade